Signal #150112 · SEC 8-K

$TNDM SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $TNDM filing catalyst

Why did $TNDM trigger an AI stock catalyst alert?

$TNDM triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +4.5/10). Headline: Tandem Diabetes Q3 Sales Rise 14% to $283.7M, Net Loss Shrinks to $0.10/Share. Key points: - Q3 sales grew 14% YoY to $283.7M, led by a 26% increase in international sales. - Net loss reduced significantly to -$7.1M (-$0.10/share) vs. -$21.2M (-$0.31/share) YoY. - Adjusted EBITDA improved to $18.0M (6% margin) compared to $2.8M (1% margin) in Q3 2025.

How did $TNDM stock react after the SEC filing?

After the SEC 8-K for $TNDM, observed market reaction: T0 price $17.99. Past moves do not guarantee future results.

Where can I get real-time $TNDM SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $TNDM via Telegram and the VIP Web Terminal from €10/month.

$TNDM

$TNDM – Tandem Diabetes Q3 Sales Rise 14% to $283.7M, Net Loss Shrinks to $0.10/Share

TANDEM DIABETES CARE INC

2026-11-05 00:00:00 UTC · SEC 8-K · All $TNDM

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+4.5 / 10)

Q3 sales grew 14% YoY to $283.7M, led by a 26% increase in international sales.
Net loss reduced significantly to -$7.1M (-$0.10/share) vs. -$21.2M (-$0.31/share) YoY.
Adjusted EBITDA improved to $18.0M (6% margin) compared to $2.8M (1% margin) in Q3 2025.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →